FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:250-251 July 27, 1995 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Magnesium was first used more than 60 years ago as a therapy for and prophylaxis against eclamptic seizures.¹ It became standard treatment over the next 30 years and was associated with a dramatic reduction in maternal and neonatal morbidity related to eclampsia.² Whether magnesium was responsible for the better outcome, however, was never tested in a randomized trial. Although newer and more effective anticonvulsant agents have become available, magnesium remains the mainstay of therapy for eclampsia. Its use has been criticized as being irrational, since it is not an anticonvulsant³ and is probably ineffective. On the other hand, it has . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Schwartz, R. B., Feske, S. K., Polak, J. F., DeGirolami, U., Iaia, A., Beckner, K. M., Bravo, S. M., Klufas, R. A., Chai, R. Y. C., Repke, J. T. (2000). Preeclampsia-Eclampsia: Clinical and Neuroradiographic Correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy. Radiology 217: 371-376 [Abstract] [Full Text]  
• (1995). Paper to change practice: Magnesium sulphate for eclampsia. DTB 33: 80-80 [Full Text]